Proactive Investors - Run By Investors For Investors
Why invest in CHM?
Chemistree Technology Inc.: DEEP DIVE

Chemistree Technologies targets burgeoning cannabis market as legalisation expands across North America

With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
Cannabis leaf
OVERVIEW: CHM The Big Picture
Currently, Chemistree has assets in both the US and Canada, including in the "enormous" Californian market

The market for cannabis stocks is white hot in Canada following the legalisation of recreational consumption on October 17, and while there has been a bit of a pullback since that milestone day, belief in the long-term outlook for the sector remains strong. But bigger news for investors is still to come.

Most observers believe that at some point, cannabis will become federally legal in the US, and when that happens the related opportunities will dwarf those in Canada.

“Enormous” California market

That view is shared by Karl Kottmeier, president of Chemistree Technologies Inc. (CSE:CHM OTCQB:CHMJF), an investment company dedicated to acquiring and developing cannabis assets in the United States and Canada.

Currently, Chemistree has assets in both the US; with its Sugar Leaf label in Washington State and prospective cannabis cultivation lands in California, and Canada through an investment in Pasha Brands, a craft cannabis firm in British Columbia.

Kottmeier says that the enormity of the Californian market is currently what makes it stand out amongst the rest, citing “far fewer barriers, greater consumption rates within the population and a massive tourist business”.

“It would be going too far to say that there is no limit, but there is certainly a vast amount of opportunity in many different areas – from cultivation to processing, innovations in cultivation and processing, distribution, marketing, branding, external mandatory testing, and so on,” he adds.

Industry veterans on board

Kottmeier says that what makes Chemistree unique is its management team, which includes several long-term players in the cannabis industry including cultivators, processors, consultants in design-build for cultivation and processing facilities, and marketers.

One name that stands out is Dennis Hunter, who Kottmeier says is “the biggest player in northern California by far when it comes to purchasing biomass, processing it and creating unique products”.

Making existing businesses better

Rather than simply buying up cultivation land, Kottmeier says the company instead looks for areas where it can deploy capital and make existing businesses better.

“The opportunities we look for revolve around the concept of making an existing business better by accessing these markets,” says Kottmeier.

“You don’t want to plant your own flag, build cultivation to the sky and hope somebody buys it off you. It is hugely competitive and good people are hard to find. Go to people who are already doing it and provide them with capital,” he adds

Sponsorship of top cannabis conference

The company is already making a move to attract those at the top of the industry, announcing on 14 November that it would be sponsoring the High Times party at the MJBizCon Conference and Expo, the premier marijuana business conference in North America.

Sponsorship of High Times and the recent launch of a new Sugarleaf website is part of an aggressive marketing and sale campaign to introduce Chemistree to cannabis retailers, starting with over 3,300 retail dispensaries and cultivators, with the majority located in California, Colorado, Arizona and Nevada.

With shares trading around C$0.39, Chemistree has a market cap of C$13.3mln.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CHM profile View Profile

Chemistree Technology Inc. Timeline

Related Articles

cannabis on dollar bills
June 08 2019
Australis invests in the highly fragmented, rapidly evolving US cannabis space, with a focus on building companies through early-stage, diversified and opportunistic investments
A cannabis plant shown next to an oil-based product
April 23 2019
THC is executing a medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets.
medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use